Opaleye Management Inc. - 04 Aug 2021 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
10%+ Owner
Signature
Opaleye Management Inc., By: /s/ James Silverman, President
Issuer symbol
ETON
Transactions as of
04 Aug 2021
Net transactions value
-$3,523,187
Form type
4
Filing time
06 Aug 2021, 21:53:44 UTC
Previous filing
22 Jul 2021
Next filing
19 Aug 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETON Common Stock, par value $0.001 per share Sale $575,140 -100,000 -2.8% $5.75 3,451,100 04 Aug 2021 By Opaleye, L.P. F1, F3
transaction ETON Common Stock, par value $0.001 per share Sale $23,006 -4,000 -2.8% $5.75 137,600 04 Aug 2021 By Managed Account F2, F3
transaction ETON Common Stock, par value $0.001 per share Sale $877,980 -150,000 -4.3% $5.85 3,301,100 05 Aug 2021 By Opaleye, L.P. F1, F4
transaction ETON Common Stock, par value $0.001 per share Sale $32,193 -5,500 -4% $5.85 132,100 05 Aug 2021 By Managed Account F2, F4
transaction ETON Common Stock, par value $0.001 per share Sale $1,927,266 -330,000 -10% $5.84 2,971,100 06 Aug 2021 By Opaleye, L.P. F1, F5
transaction ETON Common Stock, par value $0.001 per share Sale $87,603 -15,000 -11% $5.84 117,100 06 Aug 2021 By Managed Account F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F2 Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Managed Account
F3 The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $5.7514. The range of sale prices on the transaction date was $5.60 to $5.98 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
F4 The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $5.8532. The range of sale prices on the transaction date was $5.53 to $6.04 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
F5 The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $5.8402. The range of sale prices on the transaction date was $5.65 to $6.3750 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.